Prevention and treatment of severe fever with thrombocytopenia syndrome: Progress and challenges
10.3760/cma.j.cn112866-20250310-00055
- VernacularTitle:发热伴血小板减少综合征防治现状及挑战与展望
- Author:
Shujun DING
1
;
Gang WANG
Author Information
1. 山东省疾病预防控制中心传染病防制所 山东省传染病智慧化监测预警和防控重点实验室（筹），济南 250014
- Publication Type:Journal Article
- Keywords:
Severe fever with thrombocytopenia syndrome;
Emerging infectious diseases;
Tick-borne diseases;
Drug development
- From:
Chinese Journal of Experimental and Clinical Virology
2025;39(2):133-135
- CountryChina
- Language:Chinese
-
Abstract:
Severe fever with thrombocytopenia syndrome (SFTS), caused by caused by Bandavirus dabieense(formerly known as severe fever with thrombocytopenia syndrome Bunyavirus, SFTSV), is a tick-borne emerging infectious disease first identified in China in 2009. Since its discovery, the epidemic has expanded to 27 provinces nationwide. This article systematically reviews the epidemiological evolution, clinical treatment and prevention challenges of SFTS in China over the past 15 years. By integrating international case studies such as Nipah virus and monkeypox, we propose strategies including adopting orphan drug development incentive policies, standardizing clinical protocols, and implementing the " One Health" concept. These recommendations aim to provide actionable pathways for SFTS prevention, treatment, and reduction of disease burden.
